9 results
DEF 14A
AUPH
Aurinia Pharmaceuticals Inc
10 May 21
Definitive proxy
4:06pm
of the independent chair or lead director, and describe his or her role and responsibilities. If the board has neither a chair that is independent nor a lead
PRE 14A
AUPH
Aurinia Pharmaceuticals Inc
27 Apr 21
Preliminary proxy
4:32pm
the identity of the independent chair or lead director, and describe his or her role and responsibilities. If the board has neither a chair
6-K
EX-99.3
5pr 3liav
28 Apr 20
Notice of Annual General and Special Meeting of Shareholders
4:30pm
6-K
EX-99.2
a3klbcd3rv
31 May 19
Notice of Annual General Meeting of Shareholders
8:26am
6-K/A
EX-99.3
r6jydiok
17 May 18
Current report (foreign) (amended)
12:00am
40FR12B/A
EX-99.36
iiblvo2 j96enrwld7
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
- Prev
- 1
- Next